Valeant Pharmaceuticals International (VRX) 118.61 $VRX
Valeant shares tumble as report questions company finances
By TOM MURPHY - AP - Wed Oct 21, 4:03PM CDT
Valeant Pharmaceuticals stock plunged Wednesday after Citron Research compared the Canadian pharmaceutical company to the collapsed energy giant Enron and accused it of creating a network of phantom pharmacies to fool auditors.
VRX: 118.61 (-28.13), VRX.TO: 154.21 (-36.64)
Valeant Dives As Short Seller Alleges Pharmacy Fraud
at Investor's Business Daily - Wed Oct 21, 4:02PM CDT
Embattled drugmaker Valeant Pharmaceuticals (VRX) tumbled nearly 40% Wednesday to a two-year low and closed down 19.2%, as short-selling outfit Citron Research charged it with a complex fraud involving multiple specialty pharmacies. Valeant responded...
AGN: 259.00 (-4.42), ENDP: 54.46 (-8.37), VRX: 118.61 (-28.13)
Work Ahead for Valeant to Get Back to 40-Week Average
at The Street - Wed Oct 21, 4:00PM CDT
Prices are trying hold around the $120 level, an older support area.
VRX: 118.61 (-28.13)
Biogen and SanDisk are big market movers
AP - Wed Oct 21, 3:42PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:
KO: 42.19 (-0.10), VRX: 118.61 (-28.13), LRCX: 70.79 (+0.76), CMG: 665.67 (-39.96), GM: 35.42 (+1.94), BA: 141.19 (+2.31), SNDK: 76.78 (+1.59), VRX.TO: 154.21 (-36.64)
Chipotle, Yahoo Sink On Price Target Cuts
at Investor's Business Daily - Wed Oct 21, 3:32PM CDT
Stocks sold off into the close after moving little in either direction through most of Wednesday's session. The Nasdaq lagged with an 0.8% loss, while the S&P 500 gave up 0.6% and the Dow Jones industrial average shed 0.3%. Volume was higher across...
AMZN: 555.77 (-5.11), VRX: 118.61 (-28.13), HA: 32.87 (+1.50), MANH: 70.08 (+3.89), UAL: 54.55 (-1.20), UA: 99.15 (-0.82), YHOO: 31.12 (-1.71), SWI: 58.31 (+8.11), CMG: 665.67 (-39.96), MCD: 102.54 (-1.30), GM: 35.42 (+1.94), GOOGL: 671.80 (-8.20), MSFT: 47.20 (-0.57), RACE: 55.00 (-5.00)
Another Biotech Sets Off More Selling
at The Street - Wed Oct 21, 3:10PM CDT
Market is feeling very jittery.
BLUE: 80.78 (+0.15), YHOO: 31.12 (-1.71), AMZN: 555.77 (-5.11), TSLA: 210.09 (-2.94), VRX: 118.61 (-28.13), SDS: 20.92 (+0.27), IBM: 140.92 (+0.28), FB: 97.11 (+0.11), CMG: 665.67 (-39.96), GM: 35.42 (+1.94), GOOGL: 671.80 (-8.20), BA: 141.19 (+2.31)
Biotech Stocks Slump Again on Valeant's 'Smoking Gun'
at The Street - Wed Oct 21, 3:02PM CDT
Biotech stocks were in the crossfire again on Wednesday as investors fled. But this time Hillary Clinton wasn't to blame.
KO: 42.19 (-0.10), VRX: 118.61 (-28.13), F: 15.41 (+0.03), KMB: 118.09 (+0.87), PFE: 33.46 (-0.54), IBB: 304.46 (-1.50), FCAU: 15.20 (-0.74), LLY: 77.01 (-0.78), TM: 123.70 (+1.49), BMY: 62.51 (-1.38), BA: 141.19 (+2.31), GM: 35.42 (+1.94), ABBV: 53.83 (-1.00), HMC: 32.70 (+0.70), RACE: 55.00 (-5.00)
Why Valeant Pharmaceuticals Plummeted Today
Brian Orelli, The Motley Fool - Motley Fool - Wed Oct 21, 2:50PM CDT
What: Valeant Pharmaceuticals was down almost 40% at one point today after Citron Research published a report claiming that the drugmaker could be "creating invoices to deceive the auditors and book revenue." A company mid-day response helped...
VRX: 118.61 (-28.13)
Stocks Fade In Afternoon; Valeant Dives
at Investor's Business Daily - Wed Oct 21, 2:13PM CDT
The major averages were mostly lower in afternoon trading Wednesday, weighed down by drugmakers. The Nasdaq was down 0.5%, the S&P 500 slipped 0.3%, and the Dow Jones industrial average was little changed. Volume on the NYSE and Nasdaq was running...
YHOO: 31.12 (-1.71), SWI: 58.31 (+8.11), VRX: 118.61 (-28.13), HA: 32.87 (+1.50), CMG: 665.67 (-39.96), MANH: 70.08 (+3.89)
Stocks Fall; Valeant Defends Accounting Practices
at The Street - Wed Oct 21, 2:02PM CDT
Stocks relinquish gains made earlier Wednesday as a selloff in Valeant Pharmaceuticals pressures the rest of the biotech sector.
TSLA: 210.09 (-2.94), BIIB: 276.34 (+10.53), F: 15.41 (+0.03), VRX: 118.61 (-28.13), KMB: 118.09 (+0.87), IBB: 304.46 (-1.50), TM: 123.70 (+1.49), SBUX: 60.53 (-0.35), YHOO: 31.12 (-1.71), CMG: 665.67 (-39.96), ABBV: 53.83 (-1.00), GOOGL: 671.80 (-8.20), HMC: 32.70 (+0.70), AAPL: 113.76 (-0.01), KO: 42.19 (-0.10), AMZN: 555.77 (-5.11), MU: 16.43 (-0.66), PFE: 33.46 (-0.54), LLY: 77.01 (-0.78), FCAU: 15.20 (-0.74), BMY: 62.51 (-1.38), BA: 141.19 (+2.31), WDC: 71.44 (-3.42), LRCX: 70.79 (+0.76), MCD: 102.54 (-1.30), GM: 35.42 (+1.94), KLAC: 63.98 (+10.12), RACE: 55.00 (-5.00), SNDK: 76.78 (+1.59)
Carl Icahn Forming Super PAC to Push Corporate Tax Reform
at The Street - Wed Oct 21, 1:26PM CDT
The CNBC 'Fast Money' traders get the latest on the Valeant Pharma stock plunge, then hear from Carl Icahn on why he's forming a super PAC focused on corporate taxes.
VRX: 118.61 (-28.13), SPY: 201.85 (-1.24), GM: 35.42 (+1.94), IBB: 304.46 (-1.50), BA: 141.19 (+2.31), AAPL: 113.76 (-0.01)
Valeant Crushed; Chart Says It's Still No Prince
at The Street - Wed Oct 21, 1:20PM CDT
While VRX shares may look enticing, this is a very cautionary situation.
VRX: 118.61 (-28.13)
Valeant (VRX) Stock Plummets as Citron Investigates, Company Responds
at The Street - Wed Oct 21, 1:11PM CDT
Valeant Pharmaceuticals (VRX) stock is plummeting in midday trading on Tuesday, despite the company's response to a report accusing it of creating a network of "phantom" pharmacies.
VRX: 118.61 (-28.13)
Valeant Pharmaceuticals Responds To Erroneous Report
CNW Group - Wed Oct 21, 12:39PM CDT
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today responded to recent accusations made regarding its financial reporting and operations.
VRX: 118.61 (-28.13), VRX.TO: 154.21 (-36.64)
Blue Chips Outperform; Ferrari Debuts Strongly
at Investor's Business Daily - Wed Oct 21, 12:33PM CDT
The Dow Jones industrial average was in the driver's seat in early afternoon trading Wednesday, while tech stocks lagged, and the S&P 500 was mostly unchanged. The Dow rose 0.4%, helped by strength in United Technologies (UTX), Travelers (TRV),...
VRX: 118.61 (-28.13), UTX: 97.97 (+2.35), WDC: 71.44 (-3.42), BA: 141.19 (+2.31), LRCX: 70.79 (+0.76), CMG: 665.67 (-39.96), CAT: 69.67 (-0.60), KLAC: 63.98 (+10.12), RACE: 55.00 (-5.00), SNDK: 76.78 (+1.59), TRV: 110.70 (+1.75)
INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Claims Against Valeant Pharmaceuticals International, Inc. and Advises Investors to Contact the Firm
Business Wire - Wed Oct 21, 12:11PM CDT
Khang & Khang LLP announces that it is investigating claims of potential misrepresentations by Valeant Pharmaceuticals International, Inc. ("Valeant" or the "Company"
(NYSE: VRX). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.
VRX: 118.61 (-28.13), VRX.TO: 154.21 (-36.64)
Targets of Market Hatred Can Change Daily
at The Street - Wed Oct 21, 12:03PM CDT
It used to be industrials, now it's health care.
TSLA: 210.09 (-2.94), VRX: 118.61 (-28.13), GE: 28.85 (+0.07), CLX: 122.06 (-0.02), VMW: 55.42 (-13.34), NKE: 132.47 (+0.10), HON: 98.77 (+0.49), UTX: 97.97 (+2.35), WMT: 58.64 (-0.11), INTC: 33.37 (-0.07), SLB: 75.63 (+0.08), K: 69.61 (+0.64), SBUX: 60.53 (-0.35), CMG: 665.67 (-39.96), HZNP: 14.83 (-0.43), COST: 155.21 (+0.65), EMC: 25.77 (-1.72), CRZO: 38.09 (-1.55), PPG: 100.64 (-0.74), BHI: 54.41 (+1.24), ETN: 52.52 (+0.15), SWKS: 77.67 (-0.62), HAL: 38.40 (+0.72), HRL: 66.61 (+0.67), NXPI: 91.32 (-0.67), BA: 141.19 (+2.31), WDC: 71.44 (-3.42), NFLX: 97.96 (-1.03), LB: 96.52 (+0.14), LRCX: 70.79 (+0.76), GM: 35.42 (+1.94), MCD: 102.54 (-1.30), DOV: 61.88 (+0.35), KLAC: 63.98 (+10.12), AVGO: 120.50 (+0.61), SNDK: 76.78 (+1.59)
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Valeant Pharmaceuticals International, Inc. - VRX
Business Wire - Wed Oct 21, 11:19AM CDT
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) resulting from allegations that Valeant may have issued materially misleading business information to the investing public.
VRX: 118.61 (-28.13), VRX.TO: 154.21 (-36.64)
INVESTOR ALERT: Investigation of Valeant Pharmaceuticals International, Inc. Announced by Law Offices of Howard G. Smith
Business Wire - Wed Oct 21, 10:40AM CDT
Law Offices of Howard G. Smith announces an investigation on behalf of investors of Valeant Pharmaceuticals International, Inc. ("Valeant" or the "Company" (NYSE: VRX) concerning the Company's and its officers' possible violations of federal securities laws.
VRX: 118.61 (-28.13), VRX.TO: 154.21 (-36.64)
Valeant shares tumble as report questions company finances
By TOM MURPHY - AP - Wed Oct 21, 4:03PM CDT
Valeant Pharmaceuticals stock plunged Wednesday after Citron Research compared the Canadian pharmaceutical company to the collapsed energy giant Enron and accused it of creating a network of phantom pharmacies to fool auditors.
VRX: 118.61 (-28.13), VRX.TO: 154.21 (-36.64)
Valeant Dives As Short Seller Alleges Pharmacy Fraud
at Investor's Business Daily - Wed Oct 21, 4:02PM CDT
Embattled drugmaker Valeant Pharmaceuticals (VRX) tumbled nearly 40% Wednesday to a two-year low and closed down 19.2%, as short-selling outfit Citron Research charged it with a complex fraud involving multiple specialty pharmacies. Valeant responded...
AGN: 259.00 (-4.42), ENDP: 54.46 (-8.37), VRX: 118.61 (-28.13)
Work Ahead for Valeant to Get Back to 40-Week Average
at The Street - Wed Oct 21, 4:00PM CDT
Prices are trying hold around the $120 level, an older support area.
VRX: 118.61 (-28.13)
Biogen and SanDisk are big market movers
AP - Wed Oct 21, 3:42PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:
KO: 42.19 (-0.10), VRX: 118.61 (-28.13), LRCX: 70.79 (+0.76), CMG: 665.67 (-39.96), GM: 35.42 (+1.94), BA: 141.19 (+2.31), SNDK: 76.78 (+1.59), VRX.TO: 154.21 (-36.64)
Chipotle, Yahoo Sink On Price Target Cuts
at Investor's Business Daily - Wed Oct 21, 3:32PM CDT
Stocks sold off into the close after moving little in either direction through most of Wednesday's session. The Nasdaq lagged with an 0.8% loss, while the S&P 500 gave up 0.6% and the Dow Jones industrial average shed 0.3%. Volume was higher across...
AMZN: 555.77 (-5.11), VRX: 118.61 (-28.13), HA: 32.87 (+1.50), MANH: 70.08 (+3.89), UAL: 54.55 (-1.20), UA: 99.15 (-0.82), YHOO: 31.12 (-1.71), SWI: 58.31 (+8.11), CMG: 665.67 (-39.96), MCD: 102.54 (-1.30), GM: 35.42 (+1.94), GOOGL: 671.80 (-8.20), MSFT: 47.20 (-0.57), RACE: 55.00 (-5.00)
Another Biotech Sets Off More Selling
at The Street - Wed Oct 21, 3:10PM CDT
Market is feeling very jittery.
BLUE: 80.78 (+0.15), YHOO: 31.12 (-1.71), AMZN: 555.77 (-5.11), TSLA: 210.09 (-2.94), VRX: 118.61 (-28.13), SDS: 20.92 (+0.27), IBM: 140.92 (+0.28), FB: 97.11 (+0.11), CMG: 665.67 (-39.96), GM: 35.42 (+1.94), GOOGL: 671.80 (-8.20), BA: 141.19 (+2.31)
Biotech Stocks Slump Again on Valeant's 'Smoking Gun'
at The Street - Wed Oct 21, 3:02PM CDT
Biotech stocks were in the crossfire again on Wednesday as investors fled. But this time Hillary Clinton wasn't to blame.
KO: 42.19 (-0.10), VRX: 118.61 (-28.13), F: 15.41 (+0.03), KMB: 118.09 (+0.87), PFE: 33.46 (-0.54), IBB: 304.46 (-1.50), FCAU: 15.20 (-0.74), LLY: 77.01 (-0.78), TM: 123.70 (+1.49), BMY: 62.51 (-1.38), BA: 141.19 (+2.31), GM: 35.42 (+1.94), ABBV: 53.83 (-1.00), HMC: 32.70 (+0.70), RACE: 55.00 (-5.00)
Why Valeant Pharmaceuticals Plummeted Today
Brian Orelli, The Motley Fool - Motley Fool - Wed Oct 21, 2:50PM CDT
What: Valeant Pharmaceuticals was down almost 40% at one point today after Citron Research published a report claiming that the drugmaker could be "creating invoices to deceive the auditors and book revenue." A company mid-day response helped...
VRX: 118.61 (-28.13)
Stocks Fade In Afternoon; Valeant Dives
at Investor's Business Daily - Wed Oct 21, 2:13PM CDT
The major averages were mostly lower in afternoon trading Wednesday, weighed down by drugmakers. The Nasdaq was down 0.5%, the S&P 500 slipped 0.3%, and the Dow Jones industrial average was little changed. Volume on the NYSE and Nasdaq was running...
YHOO: 31.12 (-1.71), SWI: 58.31 (+8.11), VRX: 118.61 (-28.13), HA: 32.87 (+1.50), CMG: 665.67 (-39.96), MANH: 70.08 (+3.89)
Stocks Fall; Valeant Defends Accounting Practices
at The Street - Wed Oct 21, 2:02PM CDT
Stocks relinquish gains made earlier Wednesday as a selloff in Valeant Pharmaceuticals pressures the rest of the biotech sector.
TSLA: 210.09 (-2.94), BIIB: 276.34 (+10.53), F: 15.41 (+0.03), VRX: 118.61 (-28.13), KMB: 118.09 (+0.87), IBB: 304.46 (-1.50), TM: 123.70 (+1.49), SBUX: 60.53 (-0.35), YHOO: 31.12 (-1.71), CMG: 665.67 (-39.96), ABBV: 53.83 (-1.00), GOOGL: 671.80 (-8.20), HMC: 32.70 (+0.70), AAPL: 113.76 (-0.01), KO: 42.19 (-0.10), AMZN: 555.77 (-5.11), MU: 16.43 (-0.66), PFE: 33.46 (-0.54), LLY: 77.01 (-0.78), FCAU: 15.20 (-0.74), BMY: 62.51 (-1.38), BA: 141.19 (+2.31), WDC: 71.44 (-3.42), LRCX: 70.79 (+0.76), MCD: 102.54 (-1.30), GM: 35.42 (+1.94), KLAC: 63.98 (+10.12), RACE: 55.00 (-5.00), SNDK: 76.78 (+1.59)
Carl Icahn Forming Super PAC to Push Corporate Tax Reform
at The Street - Wed Oct 21, 1:26PM CDT
The CNBC 'Fast Money' traders get the latest on the Valeant Pharma stock plunge, then hear from Carl Icahn on why he's forming a super PAC focused on corporate taxes.
VRX: 118.61 (-28.13), SPY: 201.85 (-1.24), GM: 35.42 (+1.94), IBB: 304.46 (-1.50), BA: 141.19 (+2.31), AAPL: 113.76 (-0.01)
Valeant Crushed; Chart Says It's Still No Prince
at The Street - Wed Oct 21, 1:20PM CDT
While VRX shares may look enticing, this is a very cautionary situation.
VRX: 118.61 (-28.13)
Valeant (VRX) Stock Plummets as Citron Investigates, Company Responds
at The Street - Wed Oct 21, 1:11PM CDT
Valeant Pharmaceuticals (VRX) stock is plummeting in midday trading on Tuesday, despite the company's response to a report accusing it of creating a network of "phantom" pharmacies.
VRX: 118.61 (-28.13)
Valeant Pharmaceuticals Responds To Erroneous Report
CNW Group - Wed Oct 21, 12:39PM CDT
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today responded to recent accusations made regarding its financial reporting and operations.
VRX: 118.61 (-28.13), VRX.TO: 154.21 (-36.64)
Blue Chips Outperform; Ferrari Debuts Strongly
at Investor's Business Daily - Wed Oct 21, 12:33PM CDT
The Dow Jones industrial average was in the driver's seat in early afternoon trading Wednesday, while tech stocks lagged, and the S&P 500 was mostly unchanged. The Dow rose 0.4%, helped by strength in United Technologies (UTX), Travelers (TRV),...
VRX: 118.61 (-28.13), UTX: 97.97 (+2.35), WDC: 71.44 (-3.42), BA: 141.19 (+2.31), LRCX: 70.79 (+0.76), CMG: 665.67 (-39.96), CAT: 69.67 (-0.60), KLAC: 63.98 (+10.12), RACE: 55.00 (-5.00), SNDK: 76.78 (+1.59), TRV: 110.70 (+1.75)
INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Claims Against Valeant Pharmaceuticals International, Inc. and Advises Investors to Contact the Firm
Business Wire - Wed Oct 21, 12:11PM CDT
Khang & Khang LLP announces that it is investigating claims of potential misrepresentations by Valeant Pharmaceuticals International, Inc. ("Valeant" or the "Company"
(NYSE: VRX). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors. VRX: 118.61 (-28.13), VRX.TO: 154.21 (-36.64)
Targets of Market Hatred Can Change Daily
at The Street - Wed Oct 21, 12:03PM CDT
It used to be industrials, now it's health care.
TSLA: 210.09 (-2.94), VRX: 118.61 (-28.13), GE: 28.85 (+0.07), CLX: 122.06 (-0.02), VMW: 55.42 (-13.34), NKE: 132.47 (+0.10), HON: 98.77 (+0.49), UTX: 97.97 (+2.35), WMT: 58.64 (-0.11), INTC: 33.37 (-0.07), SLB: 75.63 (+0.08), K: 69.61 (+0.64), SBUX: 60.53 (-0.35), CMG: 665.67 (-39.96), HZNP: 14.83 (-0.43), COST: 155.21 (+0.65), EMC: 25.77 (-1.72), CRZO: 38.09 (-1.55), PPG: 100.64 (-0.74), BHI: 54.41 (+1.24), ETN: 52.52 (+0.15), SWKS: 77.67 (-0.62), HAL: 38.40 (+0.72), HRL: 66.61 (+0.67), NXPI: 91.32 (-0.67), BA: 141.19 (+2.31), WDC: 71.44 (-3.42), NFLX: 97.96 (-1.03), LB: 96.52 (+0.14), LRCX: 70.79 (+0.76), GM: 35.42 (+1.94), MCD: 102.54 (-1.30), DOV: 61.88 (+0.35), KLAC: 63.98 (+10.12), AVGO: 120.50 (+0.61), SNDK: 76.78 (+1.59)
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Valeant Pharmaceuticals International, Inc. - VRX
Business Wire - Wed Oct 21, 11:19AM CDT
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) resulting from allegations that Valeant may have issued materially misleading business information to the investing public.
VRX: 118.61 (-28.13), VRX.TO: 154.21 (-36.64)
INVESTOR ALERT: Investigation of Valeant Pharmaceuticals International, Inc. Announced by Law Offices of Howard G. Smith
Business Wire - Wed Oct 21, 10:40AM CDT
Law Offices of Howard G. Smith announces an investigation on behalf of investors of Valeant Pharmaceuticals International, Inc. ("Valeant" or the "Company"
(NYSE: VRX) concerning the Company's and its officers' possible violations of federal securities laws. VRX: 118.61 (-28.13), VRX.TO: 154.21 (-36.64)
